Given that increased IL-6 and IL-8 in lung fluid, sputum, and blood have been associated with clinical diseases, including chronic obstructive pulmonary disease and asthma, we believe that these in vitro results are applicable to lung inflammation and other human health effects. Here, CXCL8 is linked to chronic obstructive pulmonary disease.